Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vivo

Currently viewing:

Administrative data

Endpoint:
in vivo mammalian cell study: DNA damage and/or repair
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
comparable to guideline study with acceptable restrictions

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1981
Report date:
1981

Materials and methods

Test guidelineopen allclose all
Qualifier:
equivalent or similar to guideline
Guideline:
EPA OTS 798.5915 (In Vivo Sister Chromatid Exchange Assay)
Version / remarks:
(1998)
Deviations:
yes
Remarks:
(4 animals per sex and dose)
Qualifier:
equivalent or similar to guideline
Guideline:
EPA OTS 798.5915 (In Vivo Sister Chromatid Exchange Assay)
Deviations:
yes
Remarks:
(4 animals per sex and dose)
Principles of method if other than guideline:
Procedure according to Perry et al. (1974), Goto et al. (1978), Allen et al. (1977), Perry et al. (1975), Marquardt et al. (1978)
PERRY, P. and S. WOLFF Nature 251 , 156-158 (1974).
GOTO, K., S. MAEDA, Y. KANO and T. SUGIYAMA Chromosoma (Berl.) 66, 351-359 (1978).
ALLEN, J.W., C F . SHULER, R.W. MENDES and S.A. LATT
Cytogenet. Cell Genet. 18, 231-237 (1977).
PERRY, P. and H.J. EVANS Nature 258, 121-125 (1975).
MARQUARDT, H. and U. BAYER Mutation Res. 56, 169-176 (1978).
GLP compliance:
no
Type of assay:
sister chromatid exchange assay

Test material

Constituent 1
Chemical structure
Reference substance name:
N,N'-hexane-1,6-diylbis[3-(3,5-di-tert-butyl-4-hydroxyphenylpropionamide]
EC Number:
245-442-7
EC Name:
N,N'-hexane-1,6-diylbis[3-(3,5-di-tert-butyl-4-hydroxyphenylpropionamide]
Cas Number:
23128-74-7
Molecular formula:
C40H64N2O4
IUPAC Name:
N,N'-hexane-1,6-diylbis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propanamide]
Details on test material:
- Physical state: solid

Test animals

Species:
hamster, Chinese
Strain:
not specified
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Weight at study initiation: 20-28 g (females), 25-30 g (males)
- Diet (e.g. ad libitum): NAFAG No. 924
- Water (e.g. ad libitum): tap water, ad libitum

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22- 24
- Humidity (%): 54-62
- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
- Vehicle(s)/solvent(s) used: 0.7% aqueous solution of CMC (carboxymethyl cellulose)
- Amount of vehicle (if gavage or dermal): 20 mL/kg bw
Details on exposure:
Two hrs before application of test or control substance each animal is applied with 5 -bromodeoxyuridine (BUdR) (45 mg tab as subcutaneous implantation in the neck (Fa. Heinrich Mack, D-Illertissen, Germany)). Twenty-four hours after administration of test substance and 2hrs after intraperitoneal injection with colcemide animals were sacrificed.
Duration of treatment / exposure:
24 hrs
Frequency of treatment:
single dose
Post exposure period:
24 hrs (test substance)
Doses / concentrationsopen allclose all
Dose / conc.:
1 500 mg/kg bw/day (actual dose received)
Dose / conc.:
3 000 mg/kg bw/day (actual dose received)
Dose / conc.:
6 000 mg/kg bw/day (actual dose received)
No. of animals per sex per dose:
4 (only chromatides of 2 animals per group and sex examined)
Control animals:
yes, concurrent vehicle
Positive control(s):
7,12-dimethylbenzanthracene
- Route of administration: oral, gavage
- Doses / concentrations: 100 mg/kg bw in 0.7% aqueous solution of sodium-carboxymethylcellulose (CMC)

Examinations

Tissues and cell types examined:
Bone marrow, 25 cells per animal in metaphase
Details of tissue and slide preparation:
Bone marrow from the shafts of both femurs was suspended in balanced salt solution and diluted to hypotonicity with distilled water, kept in a waterbath at 4 to 6°C for 23 min and then centrifuged for 10 min at 200 x g. The pellets were then fixed in methanol-acetic acid 3:1 for a period of 30 min, resuspended, centrifuged for 5 min at 150 x g, and stored in renewed fixative overnight at 4°C. Finally the pellets again were centrifuged for 5 min at 150 x g, and resuspended in some 0.5 mL fixative.
These specimens were pipetted onto wet slides and air-dried. The air-dried slides then were treated with a solution of bisbenzimide for 15 min, rinsed in McIlvaine-buffer pH 8.0 and irradiated in this buffer at 50°C with UV-light of 350 nm. Following the development of the fluorochrome-UV-light reaction in 60°C 2 x SSC (standard sodium citrate) for 90 min, the slides were stained in 40% Giemsa for 20-40 min, well rinsed, cleared in Xylol and mounted in Eukitt.
The slides of two female and two male animals each of the treatment groups and of the control groups were examined. Twenty-five differently stained metaphases of the second cell-cycle with 5-bromodeoxyuridine (BUdR)-substitution were analysed.
Evaluation criteria:
Analyze of Sister Chromatide Exchanges (SCE's) according to Marquardt et al. (1978)
MARQUARDT, H. and BAYER, U. Mutation Res. 56, 169-176 (1978).
Statistics:
Significance of differences between treatment and control group was assessed by the t-test (p < 0.01)

Results and discussion

Test results
Sex:
male/female
Genotoxicity:
negative
Toxicity:
no effects
Vehicle controls validity:
valid
Negative controls validity:
not examined
Positive controls validity:
valid
Additional information on results:
When comparing the number of SCE’s between negative control and the test groups (1500, 3000 and 6000 mg/kg bw test substance) no statistical difference between treated groups and control could be seen. In contrast, the positive control group showed a highly significant increase of SCE's per cell (12.8) in comparison with the negative control (5.28 SCE's/cell).

Any other information on results incl. tables

Table 1: The effect of test substance on bone marrow cells of chinese hamster

Group

Dose [mg/kg]

 overall no of animals
 (male+ female)

group mean no.
 of SCE's

standard-
deviation

t-value

Control (0.7% CMC in water)

 

 2m +2f

5.28

2.95

 

Control (DMBA)

100

 2m +2f

12.79

6.25

10.88*

Test substance

1500

 2m +2f

6.02

3.16

1.72

Test substance

3000

 2m +2f

4.81

2.37

1.24

Test substance

6000

 2m +2f

4.88

3.91

0.82

* p≤ 0.01

DMBA= 7,12 Dimethylbenzanthracene

Applicant's summary and conclusion